Le Lézard
Classified in: Health
Subjects: PET, MRR

Animal health market: A high revenue generating industry with revenue crossing US$ 112.0 billion by 2030 - Analyzed on Horizon Databook by Grand View Research, Inc.


SAN FRANCISCO, July 3, 2024 /PRNewswire/ -- Increasing pet ownership and the trend of treating pets as family members, the rising demand for livestock products due to a growing global population, and the need to manage zoonotic diseases to protect public health are some factors driving the animal health market. The global animal health market was valued at US$ 66.0 billion in 2023 and is likely to grow at a CAGR of 9.0% from 2025 to 2030 as reported by Grand View Research, Inc.

Grand_View_Research_Logo

Technological advancements in diagnostics, biotechnology, and digital health tools enhance disease detection and treatment, while stringent regulatory environments ensure the safety and efficacy of health products. Economic growth, especially in emerging markets, leads to higher spending on pet and livestock care, and improvements in veterinary infrastructure enhance access to healthcare services. Lastly, ongoing research and development efforts drive innovation in treatments and preventive measures, contributing to overall market growth.

Horizon has a wide array of animal health topics within its database. Here are the top 10 trending animal health markets:

About Horizon Databook ? The most extensive market research database

Horizon Databook is the largest market research database with over 1 million data points across 20,000+ markets. The platform is first-in-class and is designed to service a full suite of market research clients. It is a one, five solution platform and includes the following: 

Sign up now for a free trial

Contact Info
201 Spear Street 1100,
San Francisco, CA, 94105, United States

+1-415-854-0727
[email protected]

Logo: https://mma.prnewswire.com/media/661327/Grand_View_Research_Logo.jpg

SOURCE Grand View Research, Inc.


These press releases may also interest you

at 08:05
Viridian Therapeutics, Inc. (the "company" or "Viridian"), a biopharmaceutical company focused on discovering and developing potential best-in-class medicines for serious and rare diseases, today announced that a majority of the independent...

at 08:01
Neuromod Devices Ltd. (Neuromod), the global medical technology business that created the first and only FDA Approved tinnitus treatment device, Lenire, has today announced the appointment of Tom Maher as General Counsel, effective July 5, 2024....

at 08:00
The "Annual GMP Master Class 2024" training has been added to ResearchAndMarkets.com's offering. cGMPs or Current Good Manufacturing Practices is a general encompassing term for the regulations that the control of all facets of life sciences...

at 08:00
The Canadian Dermatology Association (CDA) is proud to announce this year's recipients of its Member Awards and Public Education Awards, following a detailed review of nominations received by the Membership and Awards Committee using a thorough...

at 08:00
IntelGenx Corp. (the "Company" or "IntelGenx" a subsidiary of IntelGenx Technologies Corp.) , has successfully completed the BUENA Alzheimer's disease (AD) study. The BUENA study was designed as a Phase 2a proof of concept study to investigate the...

at 08:00
Johnson & Johnson announced today that Health Canada, through a Priority Review, has issued a Notice of Compliance (NOC) for...



News published on and distributed by: